Document is current
Any future updates will be listed below
-
Authors
Neyrinck, Audrey M.
Ahmed, Hany
Leyrolle, Quentin
Leclercq, Sophie
Amadieu, Camille
Meuronen, Topi
Layé, Sophie
Cani, Patrice D.
Kärkkäinen, Olli
Bindels, Laure B.
Hanhineva, Kati
Delzenne, Nathalie M.
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-19-NEUR-0003-03)
Research Council of Finland
FNRS (PDR T.0068.19 and PINT‐MULTI R.8013.19)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 16 April 2025
First Online: 2 May 2025
Declarations
:
: OK and KH are founders of Afekta Technologies Ltd. PDC is inventor on patent applications dealing with the use of gut bacteria and their components in the treatment of diseases. PDC was co-founder of The Akkermansia Company and Enterosys. The other authors report no financial interests or potential conflicts of interest.
